All News
STAT+: FDA chief’s goals of ‘radical transparency’ threatened by agency cuts
FDA chief wants more transparency and fewer conflicts of interest. Staff warn cuts may do the opposite.
Read MoreOpinion: The decades-long journey to Gilead’s twice-a-year HIV prevention drug lenacapavir
Gilead’s twice-a-year HIV prevention drug lenacapavir is 30 years in the making. Here’s the story behind it.
Read MoreOpinion: STAT+: Health care costs: one of the biggest obstacles to reshoring American industry
If the U.S. is serious about reshoring manufacturing jobs, it needs to address the factors that lead to offshoring those jobs in the first place, including health care costs.
Read MoreNutraceuticals in preventive care: A new frontier for general practitioners
Satya Dev Tiwari highlights how nutraceuticals can equip general practitioners to adopt a prevention-led care model, aligning with broader shifts in healthcare delivery and patient engagement
Read MoreMajority of children will be overweight or obese in nine areas of England by 2035, study shows
Exclusive: Analysis by Royal Society for Public Health suggests obesity rates will rise in 90% of the countryThe majority of children will be overweight or obese in nine areas of England by 2035, acco
Read MorePenumbra to gain market share in peripheral embolisation coils with Ruby XL system: GlobalData
FDA approval of the Ruby XL system expands Penumbra’s peripheral embolisation capabilities, positioning the company for potential market growth, according to GlobalData
Read MoreNHS begins mass rollout of weight-loss jabs to patients in England
About 220,000 patients expected to receive Mounjaro over three years as GPs can prescribe the drugs for the first timeThousands of patients in England will be able to access weight-loss jabs via their
Read MoreLiving Without Health Insurance? We Want To Hear From You
KFF Health News is documenting this moment, the first explicit rollback of health coverage since the advent of the modern U.S. health system in the early 20th century, and we want to hear from you.
Read More'5 Years, 10 Years at Most, I'm Going to Retire': What We Heard This Week
(MedPage Today) -- "A lot of my friends are in their late 50s, and they're already talking about, 'OK, maybe in the next 5 years, 10 years at most, I'm going to retire.
Read MoreOnce-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes
(MedPage Today) -- CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the phase III QWINT development program found.
Read More